The novel treatment of the medication represents a major development in the management of type 2 diabetes. Distinct from existing medications, tirzepatide impacts dual pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide625643.newbigblog.com/48994209/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment